全文获取类型
收费全文 | 417篇 |
免费 | 3篇 |
专业分类
耳鼻咽喉 | 1篇 |
妇产科学 | 1篇 |
基础医学 | 4篇 |
临床医学 | 120篇 |
内科学 | 12篇 |
神经病学 | 247篇 |
特种医学 | 8篇 |
外科学 | 20篇 |
预防医学 | 1篇 |
药学 | 2篇 |
肿瘤学 | 4篇 |
出版年
2018年 | 3篇 |
2017年 | 6篇 |
2015年 | 3篇 |
2014年 | 5篇 |
2013年 | 14篇 |
2012年 | 31篇 |
2011年 | 30篇 |
2010年 | 18篇 |
2009年 | 43篇 |
2008年 | 25篇 |
2007年 | 27篇 |
2006年 | 21篇 |
2005年 | 18篇 |
2004年 | 23篇 |
2003年 | 15篇 |
2002年 | 7篇 |
2001年 | 12篇 |
2000年 | 14篇 |
1999年 | 7篇 |
1998年 | 7篇 |
1997年 | 5篇 |
1996年 | 2篇 |
1995年 | 5篇 |
1994年 | 5篇 |
1993年 | 7篇 |
1992年 | 6篇 |
1991年 | 7篇 |
1990年 | 6篇 |
1989年 | 2篇 |
1988年 | 10篇 |
1987年 | 9篇 |
1986年 | 10篇 |
1985年 | 1篇 |
1984年 | 3篇 |
1983年 | 3篇 |
1982年 | 1篇 |
1981年 | 1篇 |
1980年 | 2篇 |
1979年 | 3篇 |
1978年 | 1篇 |
1976年 | 1篇 |
1975年 | 1篇 |
排序方式: 共有420条查询结果,搜索用时 15 毫秒
1.
G Bussone L La Mantia E A Parati F Frediani E Lamperti A Boiardi C Peccarisi A M Tortorano M A Viviani 《European neurology》1986,25(4):256-261
A case of cryptococcal meningoencephalitis, as presented by a hypertensive hydrocephalus, is described. To our knowledge, this is the 24th case described in Italy since 1953. The diagnosis was made with ventricular fluid examination: the patient was successfully treated with amphotericin B and 5-fluorocytosine, thus avoiding the risks of surgical treatment of hydrocephalus. Early diagnosis and proper therapy are necessary in order to decrease the high lethality of cryptococcosis. 相似文献
2.
3.
dOnofrio F. Cologno D. Petretta V. Casucci G. Bussone G. 《Neurological sciences》2007,28(2):S239-S241
Neurological Sciences - Basilar-type migraine (BM) has been recognised in the revised International Classification of Headache Disorders as a distinct clinical entity (subtype of migraine with... 相似文献
4.
Neurological Sciences - Chronic headaches have increasingly become a focus within the field of head pain. Most patients with frequent headache eventually overuse their medications, and when it... 相似文献
5.
Boiardi A. Gemma M. Porta E. Peccarisi C. Bussone G. 《The Italian Journal of Neurological Sciences》1986,7(5):531-534
15 chronic cluster headache patients in whom pain was induced by nitroglycerin received acute intravenous treatment with a
calcium entry blocker. At the time of peak pain we noted a sudden decrease after the Verapamil injection. The mechanism by
which the calcium entry blocker afforded relief is unlikely to have been vasodilatation in patients whose blood vessels had
just been dilated by nitroglycerin. A more probable mechanism is blockade of the release of the pain-inducing neurotransmitters.
The vasodilatation phase is not a primary factor in the onset of pain.
Sommario Sono stati studiati 15 soggetti affetti da Cluster cronica inducendo loro la crisi dolorosa con Trinitrina, trattandoli poi con calcio antagonista (Verapamil) per via endovenosa. Al momento dell'apice del dolore, valutato dal paziente con un analogo visivo, la somministrazione di Verapamil endovena, determina una rapida estinzione del dolore. L'azione efficace del Ca-antagonista non può sicuramente essere rapportata alla vasodilatazione poiché la crisi dolorosa insorge già in una fase di vasodilatazione per l'azione della Trinitina. Il meccanismo d'azione più probabile è il blocco del release di neurotrasmettitori inducenti l'attacco doloroso. Si sottolinea che la vasodilatazione non è il fattore primario dell'induzione del dolore.相似文献
6.
7.
Marco Aguggia M. G. Saracco M. Cavallini G. Bussone P. Cortelli 《Neurological sciences》2013,34(1):37-40
Migraine is often accompanied with signs of increased intracranial and extracranial mechanical sensitivities. The prevailing view today is that migraine headache is a neurovascular disorder with intracranial origin and involvement of meningeal blood vessels and their pain nerve fibers. Allodynia, defined as perception of pain following not painful stimulation, is a common clinical feature in various pain syndromes, and as part of migraine pain, it can be considered an indicator of trigeminal neural network sensitization. The cutaneous allodynia that accompanies the migraine headache in a large percentage of patients may be considered the clinical expression of central nervous system sensitization and is characterized by pain provoked by stimulation of the skin that would ordinarily not produce pain. An altered codification process of sensory impulses in the brainstem, in particular by the nucleus caudalis trigeminalis, may justify the temporal aspects and symptoms in the course of migraine attack. 相似文献
8.
Massimo Leone Alberto Proietti Cecchini Vincenzo Tullo Marcella Curone Paola Di Fiore Gennaro Bussone 《Neurological sciences》2013,34(1):71-74
Mitochondrial disorders are caused by impairment of the respiratory chain. Psychiatric features often represent part of their clinical spectrum. However, the real incidence of psychiatric disorders in these diseases is unknown. The aim of this study was to evaluate psychiatric involvement in a group of patients with mitochondrial disorders and without already diagnosed mental illness. Twenty-four patients with mitochondrial disorder and without already diagnosed mental diseases have been studied by means of the mini-international neuropsychiatric interview (MINI) and the newcastle mitochondrial diseases adult scale (NMDAS). In patients with mitochondrial disease, psychiatric conditions were far more common than in general Italian population (about 60 vs. 20–25%), and included major depression, agoraphobia and/or panic disorder, generalized anxiety disorder, social anxiety disorder, psychotic syndromes. Psychiatric involvement did not seem to depend on disease progression. Large, multicenter studies are strongly needed to better characterize the natural history of mitochondrial disorders and of their psychiatric involvement. Moreover, the possibility of mitochondrial diseases should be considered in patients with psychiatric diseases. Finally, we encourage psychiatric evaluation as a routinary approach to mitochondrial patients. 相似文献
9.
O. Gambini B. Biagianti L. Grazzi S. Usai S. Scarone G. Bussone 《Neurological sciences》2013,34(1):61-66
Psychiatric disorders in migraine patients have a higher prevalence than general population. The presence of psychiatric comorbidities may influence the complexity of the migraine pictures and be related to medication overuse. Severely impaired chronic migraineurs presenting with medication overuse are a challenge for headache clinics. Psychiatric comorbities, such as dependency-like behaviors, anxiety and mood symptoms, might account for headache-related disability and recurrent relapses into medication overuse after a successful detoxification. Within a sample of 63 chronic migraineurs with medication overuse and severe disability, we investigated to which extent clinical severity, affective states and attitudes about medication impact the overall functioning at time of detoxification. To unravel whether some of these factors could predict their long-term outcome, we followed and retest them 1 year after withdrawal. We hypothesized that the detoxification would have led to a partial improvement and not modified the attitudes toward medication and dependence. Detoxification improves most of the clinical and affective measures, but does not free from significant levels of pain intensity and headache-related disability. The partial benefit from detoxification, the severity bias and the maladaptive cognitive profile led us to believe that subgroups of chronic-relapsing migraineurs deserve a multidisciplinary approach that addresses not only the reduction of clinical severity but also specific cognitive and behavioral impairments. 相似文献
10.
G. Allais V. Tullo S. Omboni D. Pezzola D. Zava C. Benedetto G. Bussone 《Neurological sciences》2013,34(1):83-86
Oral contraceptive-induced menstrual migraine (OCMM) is a particularly severe form of migraine triggered by the cyclic hormone withdrawal. To review the efficacy of frovatriptan vs. other triptans, in the acute treatment of OCMM through a pooled analysis of three individual randomized Italian studies. With or without aura migraineurs were randomized to frovatriptan 2.5 mg or rizatriptan 10 mg (study 1), frovatriptan 2.5 mg or zolmitriptan 2.5 mg (study 2), frovatriptan 2.5 mg or almotriptan 12.5 mg (study 3). All studies had a multicenter, randomized, double-blind, crossover design. After treating 1–3 episodes of migraine in 3 months with the first treatment, patients switched to the other treatment for the next 3 months. In this analysis, the subset of 35 of the 280 women of the intention-to-treat population taking combined oral contraceptives and experiencing a migraine attack during the withdrawal phase, were analyzed. The proportion of pain free and pain relief at 2 h were 25 and 51 % with frovatriptan and 28 and 48 % with comparators (p = NS). At 24 h, 71 and 83 % of frovatriptan-treated patients and 60 and 76 % of comparator-treated patients were pain free (p < 0.05 between treatments) and had pain relief (p = NS), respectively. Relapse at 24 and 48 h was significantly (p < 0.05) lower with frovatriptan (17 and 21 %) than with the comparators (27 and 31 %). Our results suggest that, due to its sustained antimigraine effect, frovatriptan may be particularly suitable for the management of OCMM than other triptans. 相似文献